Notice to Purchaser: Limited License
The MegaBACE instrument is a confocal scanning system licensed under
US Patent Numbers 5,091,652 and 5,274,240, and corresponding foreign patents
and patent applications, including any continuations, continuations-in-part, and
subdivisions and the like.
The instrument is also an Authorized DNA Sequencer. It is authorized under
one or more US Patent Numbers 4,849,513; 5,171,534; 5,015,733; 5,118,800;
5,161,507; 5,118,802; 4,855,225; and 5,366,860, and corresponding foreign
patents and patent applications. The purchase of this instrument includes limited,
non-exclusive rights under the subject patents to use this instrument for sequencing
and fragment length analysis when used with Authorized Reagents. The use of
this instrument with Authorized Reagents provides a limited license to perform
DNA sequencing and fragment length analysis in accordance with the label rights
accompanying such reagents. Purchase of this instrument does not itself convey
to the purchaser a complete license to perform DNA sequencing and fragment
length analysis under the subject patents. Authorized reagents may be obtained
from licensed vendors, or reagents may be authorized under separate license
arrangements from PE Applied Biosystems. The above patent rights are granted
solely for research and other uses that are not unlawful. No other licenses are
granted expressly, impliedly, or by estoppel.
Further information on purchasing licenses to perform DNA sequencing and
fragment length analysis may be obtained by contacting the Director of Licensing
at PE Applied Biosystems, 850 Lincoln Center Drive, Foster City, California 94404.
PE Applied Biosystems does not guarantee the performance of this instrument.
Amersham Biosciences Limited is a licensed vendor for authorized reagents.
The MegaBACE SNuPe genotyping kit is supplied under license from Orchid
BioSciences Inc and is covered by US patent numbers 5,888,819; 6,004,744,
and foreign equivalents.
The method for serially injecting multiple plates during a single run on a
capillary-array-electrophoresis instrument is covered by US patent number
6,156,178.
Amersham Biosciences UK Limited
Amersham Place
Little Chalfont
Buckinghamshire
England HP7 9NA
Amersham Biosciences AB
SE-751 84 Uppsala
Sweden
Amersham Biosciences Corp
800 Centennial Avenue
PO Box 1327
Piscataway
NJ 08855
USA
Amersham Biosciences Europe GmbH
Munzinger Strasse 9
D-79111 Freiburg
Germany
Amersham Biosciences (SV) Corp
928 East Arques Avenue
Sunnyvale
CA 94085-4520
USA